TSS
CCCC icon

Two Sigma Securities’s C4 Therapeutics CCCC Stock Holding History

Two Sigma Securities’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.8K Buy
+10,203
New +$24K ﹤0.01% 1332
2025
Q3 		– Sell
-10,589
Closed -$15.1K – 1452
2025
Q2 		$15.1K Buy
+10,589
New +$15.4K ﹤0.01% 1255

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Securities's CCCC Position: Q1 2026 in Review

Two Sigma Securities opened a new position in C4 Therapeutics (CCCC) in Q1 2026: 10,203 shares worth $26.8K. The stake represents ﹤0.01% of the portfolio and ranks #1332 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CCCC as recently as Q2 2025.

Two Sigma Securities first reported a position in CCCC in Q2 2025 and has held it in 2 quarters since. 123 funds tracked by Wall St. Rank hold CCCC as of Q1 2026.

  • Two Sigma Securities held 10,203 shares of C4 Therapeutics worth $26.8K as of Q1 2026.
  • C4 Therapeutics was a new Two Sigma Securities position in Q1 2026.
  • C4 Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1332 holding.
  • Two Sigma Securities first reported a position in C4 Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.